As of 1:23pm ET
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Repros Therapeutics Inc have a median target of 2.25, with a high estimate of 3.50 and a low estimate of 1.00. The median estimate represents a +150.00% increase from the last price of 0.90.
The current consensus among 3 polled investment analysts is to Buy stock in Repros Therapeutics Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.